✦ LIBER ✦
Phase IB study of methoxymorpholinodoxorubicin (PNU 152243; FCE 23762) administered in a 3 or 4 weekly schedule
✍ Scribed by de Takats, P.G; Dunlop, D.; Kaye, S.B.; Fyfe, D.W.; Baker, P.; Pacciarini, M.A.; Valota, O.; Kerr, D.J.
- Book ID
- 123305042
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 392 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.